Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2005, p. 3324-3337, Vol. 25, No. 8
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.8.3324-3337.2005
,
Howard Donninger,
Chad A. Ellis,
Geoffrey J. Clark, and
Michael J. Birrer*
Cell and Cancer Biology Department, Center for Cancer Research, National Cancer Institute, Rockville, Maryland
Received 27 July 2004/ Returned for modification 8 September 2004/ Accepted 14 January 2005
The c-Jun/AP-1 transcription complex is associated with diverse cellular processes such as differentiation, proliferation, transformation, and apoptosis. These different biological endpoints are likely achieved by the regulation of specific target gene expression. We describe the identification of Ras guanine nucleotide exchange factor 1, Ras-GRF1, by microarray analysis as a c-Jun/AP-1 regulated gene essential for anchorage-independent growth of immortalized rat fibroblasts. Increased Ras-GRF1 expression, in response to inducible c-Jun expression in Rat1a fibroblasts, was confirmed by both real-time PCR and Northern blot analysis. We show that c-Jun/AP-1 can bind and activate the Ras-GRF1 promoter in vivo. A 75-kDa c-Jun/AP-1-inducible protein, p75-Ras-GRF1, was detected, and the inhibition of its expression with antisense oligomers significantly blocked c-Jun-regulated anchorage-independent cell growth. p75-Ras-GRF1 expression occurred with a concomitant increase in activated Ras (GTP bound), and the activation of Ras was significantly inhibited by antisense Ras-GRF1 oligomers. Moreover, p75-Ras-GRF1 could be coprecipitated with a Ras dominant-negative glutathione S-transferase (GST) construct, GST-Ras15A, demonstrating an interaction between p75-Ras-GRF1 and Ras. A downstream target of Ras activation, Elk-1, had increased transcriptional activity in c-Jun-expressing cells, and this activation was inhibited by dominant-negative Ras. In addition, c-Jun overexpression resulted in an increase in phospho-AKT while phosphorylation of ERK1/2 remained largely unaffected. The inhibition of phosphatidylinositol 3-kinase (PI3K)-AKT signal transduction by Ly294002
This article has been cited by other articles:
* Corresponding author. Mailing address: National Cancer Institute, 9610 Medical Center Dr., Room 300, Rockville, MD 20850-3300. Phone: (301) 402-9586. Fax: (301) 402-4422. E-mail: birrerm{at}mail.nih.gov.
Present address: Division of Medical Biochemistry, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Molecular and Cellular Biology, April 2005, p. 3324-3337, Vol. 25, No. 8
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.8.3324-3337.2005
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»